Clinical observation on acupoint massage for the treatment of blood stasis impediment type diabetic peripheral neuropathy
Objective:To observe the effects of acupoint massage on clinical symptoms and nerve conduction velocity in patients with diabetic peripheral neuropathy(DPN).Methods:A total of 120 patients with blood stasis impediment type DPN admitted to Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine during the period of January-June 2022 were selected.According to the order of admission,the random number table method was chosen to divide them into three groups:the control group,the methylcobalamin group,and the acupressure group,with 40 cases in each group.On the basis of conventional basic treatment,no other treatment was given to the control group;the methylcobalamin group was given oral methylcobalamin tablets,0.5 mg each time,three times a day;the acupressure group was given 10 acupoint massages,such as Qiaogong,Neiguan(PC6),Xuehai(SP10),Weizhong(BL40),Chengshan(BL57),Zusanli(ST36),Sanyinjiao(SP6),Taixi(KI3),Taichong(LR3),Neiting(ST44),with each acupoint being massaged for about 3 minutes,and the continuous massage lasting for about 20 minutes,five times a week for 2 weeks.The changes in clinical symptom scores,sensory nerve conduction velocity(SCV)of tibial nerves and superficial peroneal nerves,TCSS scores before and after treatment in each group were analysised.Results:After treatment,the clinical symptom scores and TCSS scores of each group were significantly reduced than that before the treatment(P<0.05),the effects of the methylcobalamin group and the acupressure group was better thant that ocntrol group(P<0.05),and the acupressure group was able to achieve the same effect as that of the methylcobalamin group.The SCV of tibial nerve and superficial peroneal nerve did not change significantly between and within groups compared with that before treatment.Conclusion:The acupressure group is able to reduce the clinical symptom score and TCSS score,and its clinical effect is comparable to that of the methylcobalamin group.